Stockreport

Aarvik Therapeutics Showcases Novel ADC Molecules Based On MUTTA™ and AQUALINK™ Platforms at AACR 2026

ArriVent BioPharma, Inc.  (AVBP) 
PDF HAYWARD, Calif.--(BUSINESS WIRE)--Aarvik Therapeutics, an innovative, ADC-focused biotechnology company dedicated to engineering precision medicines for cancer thera [Read more]